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Abstract
Background:  Biomarkers for mercury (Hg) exposure have frequently been used to assess
exposure and risk in various groups of the general population. We have evaluated the most
frequently used biomarkers and the physiology on which they are based, to explore the inter-
individual variations and their suitability for exposure assessment.
Methods: Concentrations of total Hg (THg), inorganic Hg (IHg) and organic Hg (OHg, assumed
to be methylmercury; MeHg) were determined in whole blood, red blood cells, plasma, hair and
urine from Swedish men and women. An automated multiple injection cold vapour atomic
fluorescence spectrophotometry analytical system for Hg analysis was developed, which provided
high sensitivity, accuracy, and precision. The distribution of the various mercury forms in the
different biological media was explored.
Results: About 90% of the mercury found in the red blood cells was in the form of MeHg with
small inter-individual variations, and part of the IHg found in the red blood cells could be attributed
to demethylated MeHg. THg in plasma was associated with both IHg and MeHg, with large inter-
individual variations in the distribution between red blood cells and plasma. THg in hair reflects
MeHg exposure at all exposure levels, and not IHg exposure. The small fraction of IHg in hair is
most probably emanating from demethylated MeHg. The inter-individual variation in the blood to
hair ratio was very large. The variability seemed to decrease with increasing OHg in blood, most
probably due to more frequent fish consumption and thereby blood concentrations approaching
steady state. THg in urine reflected IHg exposure, also at very low IHg exposure levels.
Conclusion: The use of THg concentration in whole blood as a proxy for MeHg exposure will
give rise to an overestimation of the MeHg exposure depending on the degree of IHg exposure,
why speciation of mercury forms is needed. THg in RBC and hair are suitable proxies for MeHg
exposure. Using THg concentration in plasma as a measure of IHg exposure can lead to significant
exposure misclassification. THg in urine is a suitable proxy for IHg exposure.
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Background
People are exposed to different forms of mercury (Hg),
which differ with respect to toxicology. The target organ
for methylmercury (MeHg) toxicity is the brain, which is
especially susceptible during development [1]. Target
organs for elemental mercury vapour (Hg0) are the brain
and kidney and the target organ for inorganic Hg com-
pounds (IHg, Hg2+) is the kidney [1]. Both MeHg and Hg0,
but not IHg, readily passes the blood-brain and placental
barriers [1]. Exposure to MeHg occurs almost exclusively
via consumption of seafood, especially predatory fish and
large marine mammals, while food in general contains
low concentrations of both MeHg and IHg [2-4]. Dental
amalgam fillings, releasing Hg0, are the major source of
Hg0 exposure in the general population [5].
In the gastrointestinal tract MeHg is absorbed to approxi-
mately 95% [6,7], Hg2+ to approximately 7% [8] and ele-
mental Hg to less than 0.01% [9,10]. The absorption of
Hg0 in the lung is about 80% [11]. Within tissues, MeHg
is slowly demethylated to Hg2+ [12,13]. In the blood, Hg0
is readily oxidized to Hg2+ by catalase [14].
The total mercury concentration (THg) in blood is often
used as a proxy measure of MeHg exposure in individuals
eating fish with the assumption that the IHg exposure,
and thereby the IHg concentration in blood, is much
lower [15-18]. In the blood, more than 90% of MeHg is
bound to haemoglobin in the red blood cells (RBC),
while IHg is more evenly distributed between RBC and
plasma [7,19]. Therefore, total Hg in RBC is also some-
times used as a proxy measure of MeHg exposure [20-23]
and total Hg in plasma is used as a proxy measure of IHg
exposure (Hg2+ and Hg0; [3,22,24-26]).
The concentration of total Hg in hair (H-THg) is often
used as a measure of MeHg exposure, assuming that >
80% of Hg in hair is in the form of MeHg [27]. Mercury is
incorporated in hair during formation in the hair follicle,
and mercury in hair is associated with the concentration
of MeHg in blood [19]. It has been proposed that H-THg
reflects inorganic mercury exposure at low MeHg exposure
in populations with no or low fish consumption [1].
The total Hg concentration in urine is used as a measure
of IHg exposure as MeHg is excreted primarily via the bile
(as glutathione complex) and faeces (about 90%; as IHg)
and only to a limited extent (about 10%) in urine (as IHg;
[1,3,28]).
The mercury biomarkers are frequently used for estima-
tion of exposure and risks of health effects, but the inter-
individual variations are not well known. The available
information on Hg kinetics is based on 25–35 years old
experimental studies, sometimes with high exposure lev-
els, involving a limited number of volunteers. The aim of
the present study was to investigate the robustness of
some of the statements forming the basis for the biomar-
kers frequently used, and to explore the inter-individual
variations. In order to do so, we have improved the tradi-
tional Magos' mercury speciation method [29,30] and
developed an automated analytical system for speciation
of mercury in whole blood, RBC, plasma, hair and urine.
Methods
Sampling
In 2003 we recruited 28 volunteers, 23 women and 5
men, 28–60 years of age (mean 48 years) for measure-
ment of Hg biomarkers. Sampling comprised venous
blood from the cubital vein (5 mL, Venoject II, EDTA(K2),
VP-050SDK), red blood cells (RBC) and plasma (5 mL,
Venoject II, EDTA(K2), VP-050SDK; Terumo Corp., Leu-
ven; Belgium), hair (a hair sample was tied with a cotton
thread, cut close to the scalp from the back of the head
and put into a plastic bag), and urine (a spot sample col-
lected in acid washed plastic containers). Information
regarding fish intake (usual number of meals/month) and
number of dental amalgam fillings was collected via self-
reported questionnaires. A usual number of 0–22 fish
meals/months and a total number of dental amalgam fill-
ings between 0–15 were reported. For evaluation of Hg
distribution in hair, and blood to hair ratio, we also used
data previously collected in a study of women with a high
fish intake (N = 145, 20–50 years of age; [31]). The study
was approved by the Ethics Committee of the Karolinska
Institutet, Stockholm.
Sample treatment
Whole blood, RBC, plasma and urine samples (1.0 mL)
were treated with 1.0 mL L-cysteine (0.012 M), 1.5 mL
NaOH (11 M) and 0.5 mL deionised water, and stored in
the dark over night at room temperature to complete the
solubilisation. Hair samples (3 cm from the scalp end;
approximately 20 mg) were treated with 2.0 mL L-cysteine
(0.083 M), 4.0 mL NaOH (11 M) and 14 mL NaCl (0.17
M). The mixture was heated to 90–95°C for 20 minutes to
complete the solubilisation.
Analyses
Total mercury (THg) and inorganic Hg (IHg) were ana-
lyzed in whole blood, RBC, plasma, hair, and urine using
cold vapour atomic fluorescence spectrophotometry
(CVAFS, Merlin, PSA 10.023; P.S. Analytical Ltd., Orping-
ton, Kent, UK), following reduction to Hg0 in a reaction
tower, using an automatic multiple-injection analysis
(MIA) system, with a Tefzel® 13-channel selector valve
(Analys Modul Sweden AB; Figure 1). In this system, a
motor-driven pump (Microlab 900, Hamilton Bonaduz
AG, Switzerland) is connected to the central port of the
selector valve, which opens to one of 13 peripheral portsEnvironmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
Page 3 of 11
(page number not for citation purposes)
at a time. The pump dispenses volumes with low variation
which enables low volumes of chemicals to be used.
Deionised water is used as an extended syringe piston and
washing medium. No chemicals or samples reach the
syringe at the base of the tube loop (Figure 1). The sam-
pler, the reaction tower and the reagent bottles are con-
nected to the peripheral ports by Tefzel®  tubes. The
sampler and the selector, with an AD converter, are con-
trolled by a PC using a control program (EASYLAB, Analys
Modul Sweden AB). The program executes the commands
from a command list for THg or IHg in a sequential or log-
ical order. In order to reduce blank values, all reagents are
initially mixed in the reaction tower to eliminate any Hg
impurities. Any Hg0 formed in this initial cleaning step is
transported with argon (Ar) gas through the detector.
For determination of IHg, 800 µl L-cysteine solution
(0.1% w/v L-cysteine in 1.5% w/v NaCl), 200 µl 8 M
H2SO4  (p.a.) with 0.4% antifoaming agent (Antifoam
204; Sigma Chemical Co., S:t Louis, MO, USA; soluble in
acid but not in alkaline solution), 2000 µl 11.25 M
NaOH, 100 µl deionised water, and 100 µl 10% w/v SnCl2
in 2.4 M H2SO4 were delivered to the reaction tower for
elimination of Hg impurities, after which 500 µl sample
solution and 200 µl cysteine solution, followed by 1200
µl of deionised water (for rinsing) were added. For deter-
mination of THg, 800 µg L-cysteine solution, 600 µl 8 M
H2SO4 with 0.4% antifoaming agent, 2000 µl 11.25 M
NaOH, 200 µl cysteine solution, 1000 µl deionised water,
and 100 µl of a mixture of 10% CdCl2 and 50% SnCl2 in
8 M H2SO4 were delivered to the reaction tower for elimi-
nation of Hg impurities. Then 500 µl 8 M H2SO4 (supra
pure) was added (in order to increase the temperature),
followed by 500 µl sample solution and 500 µl deionised
water.
The Hg0 released from the sample was transported by Ar
gas (0.087 L/min) through a moisture trap, chilled with
ice, followed by a tubular permeable membrane (Perma
Pure mini-dryers, model MD-125-12S, Perma Pure Prod-
ucts, Inc, Farmingdale, USA) before reaching the AFS
detector. The signal was stored by the PC and also
recorded on paper for process control (Perkin Elmer
Model 56 recorder). The area under the curve was inte-
grated by the computer and used for evaluation of the
amount (ng) Hg in the sample. The shield gas flow (Ar)
The automatic mercury analysis system Figure 1
The automatic mercury analysis system. The automatic multiple-injection analysis (MIA) system, with a Tefzel 13-channel 
selector valve (Analys Modul Sweden AB) for mercury analysis.Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
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for the detector was 0.099 L Ar/min. The standard solu-
tions (0.1–2.0 ng Hg/mL) were made in 0.1% L-cysteine.
Furthermore, a MeHg standard of 0.4 ng/mL was included
in the standard curve in order to control the degree of
demethylation in the IHg analysis and for recovery in the
THg analysis. The time interval between reactions was 15
minutes. All samples were analyzed in duplicates.
The concentrations of the organic mercury fraction (OHg)
were calculated by the subtraction of the IHg concentra-
tions from that of the THg concentrations. OHg is
assumed to be mainly MeHg as the only other known
exposure sources of organic mercury compounds in Swe-
den are a few vaccines containing thiomersal (ethylmercu-
rithiosalicylate), a seldom-used preservative containing
ethylmercury. Hg concentrations in urine were adjusted to
specific gravity (1.019 µg/mL; urine specific gravity refrac-
tometer, Uricon-Ne, Atago Co., Ltd., Tokyo, Japan) and
creatinine (analyzed at the Department of Clinical chem-
istry, Karolinska University Hospital, Stockholm). Hae-
matocrit and haemoglobin (Hb) concentrations were
measured (Department of Clinical chemistry, Karolinska
University Hospital, Stockholm).
Evaluation of MeHg demethylation during sample 
treatment and analysis
For evaluation of potential demethylation during solubi-
lisation, a purified (> 99%) radiolabeled methylmercury-
chloride (203Hg, Amersham Laboratories, Amersham, UK)
solution was solubilised according to the method
described above, at room temperature and at 88°C for
one hour. The total Hg concentration was measured by
gamma-counting (Searle 1195, Searle Analytical Inc.). The
loss of total Hg during solubilisation was < 1%, i.e. not
detectable. An aliquot (10 g) of each of the solubilised
solutions was acidified by 3 mL 6 M HCl, stored over
night at +4°C, extracted with chloroform three times
(30+20+10 mL) to separate MeHg and IHg [32]. The water
phase, containing the IHg from MeHg demethylation, was
then measured by gamma-counting to calculate the
degree of demethylation during solubilisation.
In order to quantify the degree of demethylation in the
reaction tower during the analytical step, samples with
and without addition of IHg and MeHg were solubilised
and then acidified and extracted with chloroform, follow-
ing the procedure described above. THg and IHg were
then measured by the analytical method described above,
and IHg from demethylation of MeHg was calculated as
the percentage of the initial amounts.
Analytical quality control
The blood sampling material was tested for Hg contami-
nation. Simulated blood sampling using a weak acid
(0.03 M HNO3) was performed. The acid solutions were
analyzed for Hg content by the method described above.
The material was found to be essentially free from Hg con-
tamination (all acid solutions were below the limit of
detection, LOD, i.e. 3 standard deviations of the mean of
the chemical blanks). All other materials used for analysis
were acid washed. Appropriate reference materials for Hg
in blood, serum, urine and hair were analyzed in each
analytical run, respectively (see Results and Table 1).
Statistics
We used spearman correlation (rs) test to test for associa-
tions between parameters, and linear regression analysis
for evaluation of association between parameters when
the requirements for normally distributed residuals were
met. Statistical analyses were conducted using SigmaStat®
(Version 2.03 for Windows (Systat Software GmbH,
Erkrath, Germany). Statistical significance was set to p <
0.05.
Results
Analytical method
The accuracy of the Hg speciation method, as evaluated by
repeated analyses of reference materials, was satisfactory
(Table 1). There are no commercially available reference
materials for IHg. However the obtained values for IHg in
blood were well in agreement with our results from previ-
ous analytical runs of the same Seronorm sample [31,33].
The analytical variability, as calculated by coefficients of
variation (CV%) of duplicate analysis of collected samples
and reference materials, was low (Table 2). The detection
limits (LOD) were lowered significantly by the introduc-
tion of the cleaning step of the reagent chemicals in the
reaction tower prior to the sample addition (Table 3). As
a result, very few samples of whole blood (n = 3), plasma
(n = 2), and RBC (n = 3) had IHg concentrations below
LOD.
Demethylation of MeHg to IHg takes place during the sol-
ubilisation of samples, and in the reaction tower, during
the analysis of the solubilised samples. After solubilisa-
tion at room temperature, acidification and extraction
with chloroform, the percentage of excess IHg from
demethylation of MeHg was 0.9 ± 0.1% (n = 4). The
demethylation after solubilisation at 88°C was 2.6 ± 0.5%
(n = 4). The acidification step, which is necessary in order
to perform the extraction, probably also, increases to a
small extent the degree of demethylation. In the reaction
tower, the percentage of excess IHg (from further demeth-
ylation of MeHg) was calculated to 3.0 ± 0.3% (n = 4).
Biomarker concentrations and correlations
A summary of the concentrations of Hg species in whole
blood (B), red blood cells (RBC), plasma (P), urine (U)
and hair (H) is given in Table 3. The correlations between
the Hg species in the various media as well as the exposureEnvironmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
Page 5 of 11
(page number not for citation purposes)
variables fish consumption (number of meals per month;
range 0–22 meals per month) and number of dental
amalgam fillings (range 0–>15), are given in Table 4. Fish
consumption was positively correlated with THg in blood
(rs = 0.74, p < 0.001), RBC, and hair, and with OHg in
blood, RBC, plasma and hair (Table 4). Fish consumption
was also correlated with IHg in hair. Number of dental
amalgam fillings was positively correlated with THg in
plasma (rs = 0.46, p = 0.01) and urine (rs = 0.49, p =
0.009), and with IHg in blood, plasma and urine (Table
4). Mercury levels in blood (THg, IHg and OHg in whole
blood, RBC or plasma) were not associated with haemo-
globin and haematocrit.
Mercury in blood
The distribution of OHg and IHg in whole blood between
RBC and plasma was calculated as the percentage of total
OHg (or IHg) in whole blood according to equation 1 and
2 (below), using individual haematocrit values (B-EVF,
%). The range of B-EVF was 35–47% (mean 42%). Data
below LOD were not included because of their
uncertainty.
1) RBC-OHg * (B-EVF/B-OHg) * 100
2) P-OHg * ((1-B-EVF)/B-OHg) * 100
On average 87% of OHg in whole blood was localized in
the RBC (95% CI of mean ± 3.7; range 76–104%; n = 20)
and 9.6% in plasma (95% CI of mean ± 1.6; range 5.1–
20%; n = 22). On average 34% of IHg in whole blood was
localized in RBC (95% CI of mean ± 4.0; range 15–54%;
n = 22) and 64% in plasma (mean; 95% CI of mean ± 5.4;
range 30–81%; n = 22). The distribution of OHg or IHg
between RBC and plasma did not change with increasing
concentrations of the respective Hg form.
The concentration of IHg in RBC was positively correlated
with both the concentration of OHg in RBC and the con-
centration of IHg in plasma (Table 4) indicating that IHg
in RBC is a function of both IHg and OHg exposures.
RBC-IHg was on average 6.8% of RBC-THg (median;
range 3.3–24%), and increased with increasing concentra-
tions of RBC-OHg (rs = 0.46; p = 0.03) and increasing con-
sumption of fish (rs = 0.60; p = 0.003), but not with
increasing number of dental amalgam fillings. In a person
with no dental amalgam fillings RBC-IHg was 4.6% of
RBC-THg.
The average RBC to plasma ratio of IHg concentrations
was 0.90 (range 0.25–2.5), or as evaluated by linear
regression, 0.50 (RBC-IHg = 0.11+0.50*P-IHg; R2 = 0.56;
Figure 2). The ratio increased with fish consumption (rs =
0.52; p = 0.008; n = 25), but not with the number of den-
tal amalgam fillings (rs = -0.23).
The average RBC to plasma ratio of OHg concentrations
was 14 (range 3.1–28). When evaluated by linear regres-
sion the ratio was also 14 (RBC-OHg = 0.20+14*P-OHg;
R2 = 0.72). The ratio did not increase with fish consump-
tion (or number of dental amalgam fillings).
Mercury in hair
The total mercury concentration in hair (H-THg) was pos-
itively correlated with B-OHg and P-OHg, as well as with
fish consumption, but not with B-IHg or the number of
dental amalgam fillings (Table 4). Speciation of Hg in hair
showed that on average 91% of THg was OHg (CI of mean
± 1.2; range 79–95%; n = 28), and 8.9% was IHg (CI of
mean ± 1.1; range 4.9–21%; n = 28). In our previous study
of women with a high fish intake, the distribution was
approximately the same, i.e. 91% of THg was OHg (CI of
mean ± 1.2; range 82–97%) and 8.7% of THg was IHg (CI
of mean ± 1.2; range 3.2–18%; n = 144). The percentage
of IHg in hair was not associated with the number of den-
tal amalgam fillings. The average percentage of IHg in hair
was 8.3% (range 4.4–13%; n = 23) in individuals without
dental amalgam fillings, and 8.8% (range 4.6–18%; n =
48) in individuals with 10 fillings or more (including data
from our previous study). The difference was not statisti-
cally significant (Student's t-test, p = 0.4). The concentra-
tion of IHg in hair was highly correlated with OHg in hair,
and with OHg in blood (B-OHg, RBC-OHg and P-OHg;
The relationship between inorganic mercury in plasma and  red blood cells Figure 2
The relationship between inorganic mercury in 
plasma and red blood cells. The relationship between 
inorganic mercury in plasma (P-IHg) and red blood cells 
(RBC-IHg) evaluated by linear regression (RBC-IHg = 
0.11+0.50 P-IHg; R2 = 0.56).Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
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Table 4), but not with IHg in blood (B-IHg, P-IHg or RBC-
IHg; Table 4). The concentration of IHg in hair was also
positively correlated with fish consumption, but not with
number of dental amalgam fillings (Table 4).
The average hair to blood ratio, (H-THg (mg/kg) divided
by B-THg (µg/L)) was 0.366 (median 0.373; 95th percen-
tile 0.552; range 0.185 to 0.673). If H-THg was divided by
B-OHg, the ratio was 0.465 (95th percentile 0.670). If we
included the hair and blood mercury data from our previ-
ous study of women with a high fish consumption the
average hair to blood ratio was 0.341 (median 0.330; 5th
percentile 0.168; 95th  percentile 0.563; range 0.066–
0.824; n = 173). The hair to blood ratio seemed to
decrease with increasing B-OHg (Figure 3).
The ratio as determined by linear regression of H-THg ver-
sus, B-THg was 0.264, i.e. H-THg = 0.179+0.264*B-THg
(R2 = 0.83; p < 0.001; n = 28). Replacing B-THg with B-
OHg only resulted in an increased intercept, to 0.282 (R2
= 0.80; n = 25). Inclusion of data from our previous study
in the linear regression analysis resulted in H-THg =
0.169+0.254*B-THg (R2 = 0.62; p < 0.001; n = 173; Figure
4).
Mercury in urine
Essentially all Hg in urine (> 98%) was IHg. IHg in urine,
adjusted to specific gravity (1.019 g/mL) or adjusted to
creatinine (g creatinine/L urine) were highly correlated
with IHg in blood, plasma and RBC, but not with OHg in
the various media (Table 4). IHg in urine was moderately
associated with the number of dental amalgam fillings,
but not with fish consumption (Table 4).
Discussion
This study of Hg biomarkers was possible due to the
improvements and modifications of the CVAFS method
used for determination of total and inorganic Hg in
blood, hair and urine. The method provides high sensitiv-
ity, low analytical variability, and high accuracy also in the
low concentration range. The limits of detection (between
0.01 and 0.09) were about 2–10 times lower than those
previously reported [18,22,23,30,34-37]. It can be con-
cluded that our modified analytical method is suitable for
the purposes of speciation of Hg in human biological
media and for evaluation of the main exposure sources.
The total variability in the different biomarkers measured
includes inter-individual differences in the Hg kinetics as
well as demethylation of MeHg to IHg during sample
treatment and analysis. We have determined the degree of
demethylation in our analytical procedure and we con-
clude that the method results in about 5% demethylation
of MeHg, half of it in the solubilisation step if samples are
heated during solubilisation (as for hair), and the other
half in the analytical step. If solubilisation takes place at
room temperature, as for blood, RBC, plasma and urine,
The hair to blood ratio of total mercury versus organic mer- cury in blood Figure 3
The hair to blood ratio of total mercury versus 
organic mercury in blood. The hair to blood ratio of total 
mercury (H-THg/B-THg) as a function of organic mercury in 
blood (B-OHg).
The relationship between total mercury in hair and blood Figure 4
The relationship between total mercury in hair and 
blood. The relationship between total mercury in hair (H-
THg) and blood (B-THg) evaluated by linear regression (H-
THg = 0.169+0.254 B-THg; R2 = 0.62).Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
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the overall demethylation is further reduced, to less than
4%. The acidification of the samples, which was a prereq-
uisite for the extraction procedure and the separation of
IHg from MeHg, may be responsible for some of the
demethylation during the tests. The demethylation of
MeHg in blood during sample preparation and analysis
has previously been reported to be 2–3% using acidic
digestion [38].
The distribution of OHg between RBC (87%) and plasma
(9.6%) was in good agreement with the earlier observa-
tions that the major part of MeHg in blood is found in the
RBC, bound to haemoglobin [6,7,19]. The inter-individ-
ual variation was relatively low (total range about 15%).
The average RBC to plasma OHg ratio of 14 found in the
present study was between the ratios of 10 [6,7] and 20
[19], previously reported. In those studies, a limited
number of volunteers (3 to 15 male and female
Table 1: Results of analytical quality control. Results (Mean; standard deviation, SD; coefficient of variation, CV%; and number, n) of 
repeated analyses of total mercury (THg) and inorganic mercury (IHg) in reference materials analyzed together with collected 
samples of whole blood, red blood cells (RBC), plasma, urine (µg/L) and hair (mg/kg).
Media Reference material THg IHg
Mean (SD) Mean (SD)
CV% (n) CV% (n)
Blood/RBC Seronorm 404107X
Rec. value THg: 3 µg/L 2.3 (0.18) 0.54 (0.051)
Range: 2.2–3.3 µg/L 8.1 (7) 9.4 (7)
Seronorm 404108
Rec. value THg: 8 µg/L 8.1 (0.52) 6.4 (0.32)
Range: 6.7–8.4 µg/L 6.3 (7) 5.0 (7)
Plasma Seronorm 201405
Rec. value THg: 0.96 µg/L 1.0 (0.081) 0.70 (0.017)
Range: 0.87–1.06 µg/L 8.0 (5) 2.4 (5)
Urine Seronorm 2524
Rec. value THg: 0.21 µg/L 0.20 (0.0068) 0.11 (0.011)
95% CI: 0.17–0.25 µg/L 3.4 (4) 10 (4)
Seronorm 2525
Rec. value THg: 40.3 µg/L 38 (1.9) 38 (0.85)
95% CI: 37.7–42.9 µg/L 5.0 (6) 2.2 (6)
Hair IAEA086
Rec. value THg: 0.573 mg/kg 0.58 (0.028) 0.27 (0.022)
95% CI: 0.534–0.612 4.8 (5) 8.1 (5)
IMM-hair1
Rec. value THg: 4.8 mg/kg 4.7 (0.14) 0.50 (0.026)
SD: 0.3 mg/kg 3.0 (5) 5.1 (5)
1 Björnberg et al. 2003
Table 2: Precision of duplicate analyses. Precision (Coefficient of variation, CV%) of duplicate analyses of total mercury (THg) and 
inorganic mercury (IHg) in blood, red blood cells (RBC), plasma, urine (µg/L) and hair (mg/kg), in collected samples and reference 
materials.
THg IHg
CV (%) No. of duplicate 
analyses
Concentration 
range
CV (%) No. of duplicate 
analyses
Concentration 
range
Blood 4.3 32 0.34–8.5 6.4 30 0.079–6.8
RBC 5.9 34 0.38–14 12 24 0.061–6.7
Plasma 5.3 29 0.048–1.3 7.3 26 0.060–1.1
Hair 2.6 32 0.081–4.9 9.0 31 0.01–0.52
Urine 3.2 35 0.19–6.2 2.5 34 0.094–6.3Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
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volunteers) were given oral doses of either a radioactive
MeHg salt in solution (about 10 µg Hg; [7]), radioactive
MeHg bound to fish muscle protein (about 10 µg Hg; [6])
or a meal of fish containing 18–22 µg Hg/kg b.w. (provid-
ing 1400 µg Hg/70 kg man; [19]). The RBC to plasma
OHg ratio in the present study was not influenced by the
mercury concentrations in blood. Thus, it seems as the
distribution of MeHg between RBC and plasma is rather
constant over a large range of exposures.
The distribution of IHg between RBC (34%) and plasma
(64%) displayed a much larger inter-individual variation
(total range about 40–50%) than that of OHg. The RBC-
IHg was positively correlated with both P-IHg and RBC-
OHg, but P-IHg was not correlated with RBC-OHg. It can
be concluded that IHg in RBC is partly emanating from
inorganic Hg exposure, mainly Hg0 via amalgam, and
partly from MeHg exposure via fish, which has demethyl-
ated to IHg in the body and, to some extent, in the analy-
sis (less than 4%). Thus, the variation in MeHg exposure
from fish adds to the variation in RBC-IHg, which can
partly explain the larger inter-individual variation meas-
ured in the distribution of IHg between RBC and plasma.
Little is known about the mechanisms involved in the
conversion of MeHg to IHg in the human body, and the
inter-individual variability. Based on our data, there
seems to be little demethylation taking place in the blood
(a few percent).
Our data strongly indicates that the small fraction of IHg
in hair (about 9%), with relatively small inter-individual
variations (CV about 15%) is a result of MeHg exposure
and demethylation of MeHg in blood or hair follicles
(and in the analysis), rather than a result of IHg exposure.
IHg in hair was positively correlated with fish intake, but
not with dental amalgam fillings. It was also highly corre-
lated with OHg in blood, RBC and plasma. The hypothe-
sis is further supported by our results in non-fish eating
individuals, which showed a positive correlation of MeHg
in blood and hair, but no correlation of IHg in blood and
hair, despite a very low MeHg exposure (B-MeHg below
1.0 µg/L; [4]). MeHg in hair has been shown to be stable
over time [39,40], indicating that demethylation within
the hair strand is very limited. However, it should be
borne in mind that artificial waving and other hair treat-
ments may reduce Hg concentrations within the hair
strand [41]. It has previously been suggested that MeHg is
demethylated to inorganic Hg in the cells of the hair folli-
Table 3: Concentrations of total, inorganic and organic mercury in various biological media. Concentrations of total mercury (THg), 
inorganic mercury (IHg) and organic mercury (OHg) in whole blood, plasma, red blood cells (RBC), urine and hair in 28 individuals, 
and limits of detection (LOD, i.e. 3 × standard deviation of mean of chemical blank/solubilisation solution; the number of samples was 
5–10) of the two chemical runs.
THg IHg OHg
Whole blood (µg/L) Mean ± SD 2.2 ± 1.4 0.35 ± 0.23 1.8 ± 1.3
Median 2.0 0.35 1.6
Range 0.34–7.3 0–0.94 0.26–6.9
LOD 0.05/0.09 0.03/0.06
Plasma (µg/L) Mean ± SD 0.65 ± 0.30 0.39 ± 0.26 0.26 ± 0.16
Median 0.63 0.37 0.22
Range 0.07–1.3 0–1.1 0.05–0.70
LOD 0.04 0.02/0.05
RBC (µg/L) Mean ± SD 4.1 ± 2.6 0.29 ± 0.18 3.8 ± 2.5
Median 4.0 0.26 3.6
Range 0.40–14 0–0.70 0.25–13
LOD 0.03/0.04 0.05/0.05
Urine (µg/L; adjusted to 
density 1.019)
Mean ± SD 1.4 ± 1.2 1.4 ± 1.2 0.012 ± 0.073
Median 1.0 1.0 0.015
Range 0.27–6.1 0.18–6.3 0–0.11
LOD 0.03/0.05 0.03/0.02
Urine (µg/g creatinine) Mean ± SD 1.9 ± 2.0 1.9 ± 2.1 0.013 ± 0.12
Median 1.3 1.2 0.018
Range 0.12–10 0.12–11 0–0.23
Hair (mg/kg) Mean ± SD 0.76 ± 0.40 0.062 ± 0.030 0.69 ± 0.37
Median 0.71 0.060 0.66
Range 0.08–2.0 0.010–0.12 0.072–1.9
LOD 0.01 0.01Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
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cle [27]. As the IHg fraction in hair was about 9% and
since the demethylation of MeHg in the hair analysis is
about 5%, the average degree of demethylation in the hair
follicles would be on average 4%. Because of the demeth-
ylation, THg in hair is a better measure of MeHg exposure
than MeHg in hair.
In humans, a frequently cited blood to hair ratio (B-
THg:H-THg) evaluated by linear regression is 1:250, how-
ever with large inter-study variations (range 140–370;
[2,28]). In the present study, the ratio as evaluated by lin-
ear regression was 1:254. When evaluating mercury blood
to hair ratios by linear regression there is always a positive
intercept. The intercept may reflect the different time
frames of the integrated exposure as measured in hair and
blood, and occasional high MeHg exposure. If the blood
to hair ratio of 1:250 is used to calculate B-MeHg from H-
THg, B-MeHg will always be underestimated due to the
positive intercept. The inter-individual variation in the
blood to hair ratio as determined by division was very
large. The variability seemed to decrease with increasing
B-OHg concentrations (Figure 3), most probably due to
more frequent fish consumption and thereby blood con-
centrations approaching steady state.
Our data shows that IHg in urine reflects the IHg exposure
as nearly all Hg in urine (> 98%) was IHg and as IHg in
urine did not reflect fish consumption or the OHg con-
centration in various media. Experimental data report
greater concentrations of Hg in kidneys in males than in
females exposed similarly [42]. A higher excretion of IHg
in urine in women (1.5 µg/L adjusted to specific gravity
1.019 g/mL and 2.1 µg/g creatinine) than in men (0.80
µg/L adjusted to specific gravity 1.019 g/mL and 0.75 µg/
g creatinine; p = 0.03) was noted in the present study,
despite a similar exposure to IHg as measured by IHg in
plasma (0.4 µg/L). However, the sample size was too
small to draw any conclusions from those data. Further
studies are warranted on gender differences in Hg metab-
olism and toxicity.
Conclusion
As expected, fish consumption was positively correlated
with THg in blood, RBC, and hair. The use of THg concen-
tration in blood as a proxy for MeHg exposure will give
rise to an overestimation of the MeHg exposure, small or
large, depending on the exposure to IHg (Hg2+ and Hg0).
In order to reduce the inter-individual variability it can be
recommended to speciate the various forms of Hg in
blood when evaluating exposure, dose and risk for health
effects. The demethylation taking place during sample
preparation and analysis with this method will lead to a
small underestimation of the MeHg concentration and an
overestimation of the IHg concentration in the sample.
The total Hg concentration in the RBC gives a good meas-
ure of the MeHg exposure at low IHg exposure levels.
Most of the Hg found in the RBC is in the form of MeHg
with small inter-individual variations. Part of the IHg in
RBC is emanating from demethylated MeHg, leaving a
small fraction of IHg that is the result of IHg exposure.
Using THg concentrations in plasma as a measure of IHg
exposure can lead to significant exposure misclassifica-
tions. The total concentration of Hg in plasma is associ-
ated with both IHg and OHg, with large inter-individual
variations in the distribution between RBC and plasma,
depending on both the MeHg and IHg exposure.
Table 4: The Spearman correlation coefficients between mercury species in different media and exposure vavariables. Spearman 
correlation coefficients of inorganic mercury (IHg) and organic mercury (OHg) species in whole blood (B; µg/L), red blood cells (RBC; 
µg/L), plasma (P; µg/L) and urine (U: µg/L, adjusted to density 1.019) and IHg, OHg and total mercury (THg) in hair (H; mg/kg) and the 
exposure variables fish consumption (number of meals per month) and number of dental amalgam fillings. The number of samples are 
25–28. The significance level is indicated as * p < 0.05; ** p < 0.01; *** p < 0.001.
B-OHg RBC-IHg RBC-OHg P-IHg P-OHg H-THg H-IHg H-OHg U-IHg U-OHg Fish Amalgam
B-IHg 0.19 0.83 *** 0.25 0.91 *** 0.05 0.28 0.29 0.27 0.81 *** -0.11 0.07 0.48 *
B-OHg 0.38 0.96 *** 0.07 0.82 *** 0.87 *** 0.79 *** 0.87 *** -0.07 0.27 0.82 *** 0.09
RBC-IHg 0.45 * 0.70 *** 0.34 0.46 * 0.42 * 0.43 * 0.73 *** 0.04 0.37 0.27
RBC-OHg 0.13 0.77 *** 0.82 *** 0.81 *** 0.81 *** 0.03 0.22 0.76 *** 0.14
P-IHg -0.13 0.16 0.16 0.14 0.74 *** -0.14 -0.04 0.49 *
P-OHg 0.77 *** 0.74 *** 0.75 *** -0.003 0.29 0.82 *** 0.06
H-THg 0.86 *** 0.99 *** 0.18 0.32 0.75 *** 0.28
H-IHg 0.83 *** 0.28 0.28 0.63 *** 0.32
H-OHg 0.17 0.31 0.74 *** 0.30
U-IHg 0.05 -0.03 0.49 **
U-OHg 0.24 -0.007
Fish 0.13Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
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The THg concentration in hair reflects MeHg exposure at
all exposure levels. The small fraction of IHg in hair is
most probably emanating from MeHg that was
demethylated in the body and during the sample prepara-
tion and analysis. IHg in hair was also correlated with fish
consumption. THg in hair seems to provide the best meas-
ure of long-term average MeHg exposure. THg in urine
reflects IHg exposure, also at very low exposure levels.
Number of dental amalgam fillings was highly positively
correlated with THg in plasma and urine.
List of abbreviations
Ar Argon
B Blood
B-EVF Blood-Erythrocyte Volume Fraction (haematocrit)
b.w. Body weight
CI Confidence interval
CV Coefficient of variation
CVAFS Cold vapour atomic fluorescence
spectrophotometry
H Hair
Hg0 Elemental mercury vapour
Hg2+ Inorganic mercury, ionic form
IHg Inorganic mercury
LOD Limit of detection
MeHg Methylmercury
MIA Multiple-injection analysis
n Number
OHg Organic mercury
P Plasma
RBC Red blood cell
Rec. value Recommended value
THg Total mercury
U Urine
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
MB participated in the design of the study, performed the
data analyses and drafted the manuscript, BL participated
in the development of the analytical method and revision
of the manuscript, KAB participated in the design of the
study and helped to draft the manuscript, BP carried out
the mercury analyses, ÖE participated in the development
of the analytical method, and MV participated in the
design of the study and the critical revision of the manu-
script. All authors read and approved the final
manuscript.
Acknowledgements
The participants of this study, and Agneta Åkesson for skilful blood sam-
pling, are gratefully acknowledged.
References
1. NRC:  Toxicological effects of methylmercury.  E d i t e d  b y :
Council NR. Washington, DC, National Academy Press; 2000:344. 
2. WHO:  Methylmercury.  I n  Environmental Health Criteria  Volume
101. Edited by: (IPCS) IPCS. Geneva, World Health Organization;
1990. 
3. WHO: Inorganic mercury.  In Environmental Health Criteria Volume
118. Edited by: (IPCS) IPCS. Geneva, World Health Organization;
1991. 
4. Lindberg A, Bjornberg KA, Vahter M, Berglund M: Exposure to
methylmercury in non-fish-eating people in Sweden.  Environ
Res 2004, 96:28-33.
5. WHO:  Elemental mercury and inorganic mercury com-
pounds: Human health aspects.  In Concise international chemical
assessment document (CICAD)  Volume 50. Geneva, World Health
Organization; 2003. 
6. Miettinen JK: Absorption and elimination of dietary (Hg2+)
and methylmercury in man.  In Mercury, Mercurial, and Mercaptans
Edited by: Miller MW and Clarkson TW. Springfield, C.C. Thomas;
1973:233-246. 
7. Aberg B, Ekman L, Falk R, Greitz U, Persson G, Snihs JO: Metabo-
lism of methyl mercury (203Hg) compounds in man.  Arch
Environ Health 1969, 19:478-484.
8. Rahola T, Hattula T, Korolainen A, Miettinen JK: Elimination of
free and protein-bound ionic mercury (20Hg2+) in man.  Ann
Clin Res 1973, 5:214-219.
9. Friberg L, Nordberg G: Inorganic mercury - a toxicological and
epidemiological appraisal.  In Mercury, Mercurials and Mercaptans
Edited by: Miller MW and Clarkson TW. Springfield, C.C. Thomas;
1973:5. 
10. Bornmann G, Henke G, Alfes H, Mollmann H: [Intestinal absorp-
tion of metallic mercury].  Arch Toxikol 1970, 26:203-209.
11. Hursh JB, Cherian MG, Clarkson TW, Vostal JJ, Mallie RV: Clearance
of mercury (HG-197, HG-203) vapor inhaled by human
subjects.  Arch Environ Health 1976, 31:302-309.
12. Vahter ME, Mottet NK, Friberg LT, Lind SB, Charleston JS, Burbacher
TM: Demethylation of methyl mercury in different brain sites
of Macaca fascicularis monkeys during long-term subclinical
methyl mercury exposure.  Toxicol Appl Pharmacol 1995,
134:273-284.
13. Dock L, Rissanen RL, Vahter M: Demethylation and placental
transfer of methyl mercury in the pregnant hamster.  Toxicol-
ogy 1994, 94:131-142.
14. Halbach S, Clarkson TW: Enzymatic oxidation of mercury
vapor by erythrocytes.  Biochim Biophys Acta 1978, 523:522-531.
15. Weil M, Bressler J, Parsons P, Bolla K, Glass T, Schwartz B: Blood
mercury levels and neurobehavioral function.  Jama 2005,
293:1875-1882.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Environmental Health: A Global Access Science Source 2005, 4:20 http://www.ehjournal.net/content/4/1/20
Page 11 of 11
(page number not for citation purposes)
16. Grandjean P, Weihe P, Jorgensen PJ, Clarkson T, Cernichiari E, Videro
T: Impact of maternal seafood diet on fetal exposure to mer-
cury, selenium, and lead.  Arch Environ Health 1992, 47:185-195.
17. Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K,
Murata K, Sorensen N, Dahl R, Jorgensen PJ: Cognitive deficit in 7-
year-old children with prenatal exposure to methylmercury.
Neurotoxicol Teratol 1997, 19:417-428.
18. Schober SE, Sinks TH, Jones RL, Bolger PM, McDowell M, Osterloh J,
Garrett ES, Canady RA, Dillon CF, Sun Y, Joseph CB, Mahaffey KR:
Blood mercury levels in US children and women of child-
bearing age, 1999-2000.  Jama 2003, 289:1667-1674.
19. Kershaw TG, Clarkson TW, Dhahir PH: The relationship
between blood levels and dose of methylmercury in man.
Arch Environ Health 1980, 35:28-36.
20. Sakamoto M, Kubota M, Matsumoto S, Nakano A, Akagi H: Declin-
ing risk of methylmercury exposure to infants during
lactation.  Environ Res 2002, 90:185-189.
21. Sakamoto M, Kubota M, Liu XJ, Murata K, Nakai K, Satoh H: Mater-
nal and fetal mercury and n-3 polyunsaturated fatty acids as
a risk and benefit of fish consumption to fetus.  Environ Sci
Technol 2004, 38:3860-3863.
22. Skerfving S: Mercury in women exposed to methylmercury
through fish consumption, and in their newborn babies and
breast milk.  Bull Environ Contam Toxicol 1988, 41:475-482.
23. Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F,
Schutz A, Stromberg U, Vessby B, Skerfving S: Markers of high fish
intake are associated with decreased risk of a first myocar-
dial infarction.  Br J Nutr 2001, 86:397-404.
24. Halbach S, Welzl G, Kremers L, Willruth H, Mehl A, Wack FX, Hickel
R, Greim H: Steady-state transfer and depletion kinetics of
mercury from amalgam fillings.  Sci Total Environ 2000,
259:13-21.
25. Bjorkman L, Sandborgh-Englund G, Ekstrand J: Mercury in saliva
and feces after removal of amalgam fillings.  Toxicol Appl
Pharmacol 1997, 144:156-162.
26. af Geijersstam E, Sandborgh-Englund G, Jonsson F, Ekstrand J: Mer-
cury uptake and kinetics after ingestion of dental amalgam.
J Dent Res 2001, 80:1793-1796.
27. Cernichiari E, Toribara TY, Liang L, Marsh DO, Berlin MW, Myers GJ,
Cox C, Shamlaye CF, Choisy O, Davidson P, Clarkson T: The bio-
logical monitoring of mercury in the Seychelles study.  Neuro-
toxicology 1995, 16:613-628.
28. Clarkson TW, Hursh JB, Sager PR, Syversen TLM: Mercury.  In Bio-
logical Monitoring of Toxic Metals Edited by: Clarkson TW, Friberg L,
Nordberg GF and Sager PR. New York and London, Plenum Press;
1988:199-246. 
29. Magos L: Selective atomic-absorption determination of inor-
ganic mercury and methylmercury in undigested biological
samples.  Analyst 1971, 96:847-853.
30. Magos L, Clarkson TW: Atomic absorption determination of
total, inorganic, and organic mercury in blood.  J Assoc Off Anal
Chem 1972, 55:966-971.
31. Bjornberg KA, Vahter M, Grawe KP, Berglund M: Methyl mercury
exposure in Swedish women with high fish consumption.  Sci
Total Environ 2005, 341:45-52.
32. Matsuo N, Suzuki T, Akagi H: Mercury concentration in organs
of contemporary Japanese.  Arch Environ Health 1989, 44:298-303.
33. Bjornberg KA, Vahter M, Petersson-Grawe K, Glynn A, Cnattingius S,
Darnerud PO, Atuma S, Aune M, Becker W, Berglund M: Methyl
mercury and inorganic mercury in Swedish pregnant women
and in cord blood: influence of fish consumption.  Environ
Health Perspect 2003, 111:637-641.
34. Mahaffey KR, Mergler D: Blood levels of total and organic mer-
cury in residents of the upper St. Lawrence River basin, Que-
bec: association with age, gender, and fish consumption.
Environ Res 1998, 77:104-114.
35. Morrissette J, Takser L, St-Amour G, Smargiassi A, Lafond J, Mergler
D: Temporal variation of blood and hair mercury levels in
pregnancy in relation to fish consumption history in a popu-
lation living along the St. Lawrence River.  Environ Res 2004,
95:363-374.
36. Muckle G, Ayotte P, Dewailly E, Jacobson SW, Jacobson JL: Deter-
minants of polychlorinated biphenyls and methylmercury
exposure in inuit women of childbearing age.  Environ Health
Perspect 2001, 109:957-963.
37. Oskarsson A, Schultz A, Skerfving S, Hallen IP, Ohlin B, Lagerkvist BJ:
Total and inorganic mercury in breast milk in relation to fish
consumption and amalgam in lactating women.  Arch Environ
Health 1996, 51:234-241.
38. Bergdahl IA, Schutz A, Hansson GA: Automated determination
of inorganic mercury in blood after sulfuric acid treatment
using cold vapour atomic absorption spectrometry and an
inductively heated gold trap.  Analyst 1995, 120:1205-1209.
39. al-Shahristani H, Shihab KM: Variation of biological half-life of
methylmercury in man.  Arch Environ Health 1974, 28:342-344.
40. Phelps RW, Clarkson TW, Kershaw TG, Wheatley B: Interrelation-
ships of blood and hair mercury concentrations in a North
American population exposed to methylmercury.  Arch Envi-
ron Health 1980, 35:161-168.
41. Yasutake A, Matsumoto M, Yamaguchi M, Hachiya N: Current hair
mercury levels in Japanese: survey in five districts.  Tohoku J
Exp Med 2003, 199:161-169.
42. Hultman P, Nielsen JB: The effect of dose, gender, and non-H-2
genes in murine mercury-induced autoimmunity.  J Autoimmun
2001, 17:27-37.